57.24
price up icon2.45%   1.37
after-market アフターアワーズ: 56.18 -1.06 -1.85%
loading
前日終値:
$55.87
開ける:
$55.16
24時間の取引高:
1.34M
Relative Volume:
0.48
時価総額:
$9.51B
収益:
$1.06B
当期純損益:
$-326.58M
株価収益率:
-27.23
EPS:
-2.1022
ネットキャッシュフロー:
$-977.73M
1週間 パフォーマンス:
+1.20%
1か月 パフォーマンス:
+4.21%
6か月 パフォーマンス:
-28.98%
1年 パフォーマンス:
+33.58%
1日の値動き範囲:
Value
$55.16
$57.24
1週間の範囲:
Value
$54.91
$57.66
52週間の値動き範囲:
Value
$41.70
$86.74

Ionis Pharmaceuticals Inc Stock (IONS) Company Profile

Name
名前
Ionis Pharmaceuticals Inc
Name
セクター
Healthcare (1080)
Name
電話
(760) 931-9200
Name
住所
2855 GAZELLE COURT, CARLSBAD, CA
Name
職員
1,402
Name
Twitter
@ionispharma
Name
次回の収益日
2026-07-29
Name
最新のSEC提出書
Name
IONS's Discussions on Twitter

Compare IONS vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IONS icon
IONS
Ionis Pharmaceuticals Inc
57.24 9.39B 1.06B -326.58M -977.73M -2.1022
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
505.75 133.25B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
803.48 82.16B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
851.29 54.80B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
203.71 43.99B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
347.48 40.62B 5.76B 514.49M 1.10B 4.4813

Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-21 開始されました Canaccord Genuity Buy
2026-04-10 再開されました Raymond James Outperform
2026-01-28 再開されました Barclays Overweight
2025-10-08 アップグレード JP Morgan Neutral → Overweight
2025-09-26 アップグレード Goldman Sell → Neutral
2025-09-03 アップグレード BMO Capital Markets Market Perform → Outperform
2025-07-31 アップグレード Morgan Stanley Equal-Weight → Overweight
2025-07-01 アップグレード Barclays Equal Weight → Overweight
2025-04-07 開始されました H.C. Wainwright Buy
2025-03-31 開始されました Redburn Atlantic Neutral
2024-08-02 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-07-24 アップグレード Leerink Partners Market Perform → Outperform
2024-07-16 再開されました Jefferies Buy
2024-06-14 アップグレード Bernstein Underperform → Mkt Perform
2024-04-10 アップグレード Wolfe Research Peer Perform → Outperform
2024-01-02 アップグレード BofA Securities Neutral → Buy
2023-10-23 アップグレード BofA Securities Underperform → Neutral
2023-09-29 開始されました Raymond James Strong Buy
2023-07-31 アップグレード Citigroup Neutral → Buy
2023-06-07 再開されました Piper Sandler Overweight
2023-05-04 アップグレード Citigroup Sell → Neutral
2023-03-21 開始されました Bernstein Underperform
2022-12-21 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-09-09 再開されました Morgan Stanley Overweight
2022-07-18 再開されました Oppenheimer Outperform
2022-03-31 再開されました Piper Sandler Overweight
2022-03-01 開始されました Citigroup Sell
2022-03-01 開始されました Guggenheim Buy
2022-02-01 ダウングレード BofA Securities Buy → Underperform
2021-12-14 アップグレード William Blair Mkt Perform → Outperform
2021-05-07 アップグレード UBS Sell → Neutral
2021-03-01 アップグレード Barclays Underweight → Equal Weight
2020-12-16 開始されました UBS Sell
2020-12-15 アップグレード Cowen Market Perform → Outperform
2020-09-14 再開されました JP Morgan Neutral
2020-09-02 開始されました The Benchmark Company Hold
2020-06-01 再開されました Oppenheimer Outperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-03-05 開始されました Citigroup Buy
2019-12-13 開始されました Oppenheimer Outperform
2019-11-13 開始されました BofA/Merrill Buy
2019-11-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-09-10 アップグレード Bernstein Mkt Perform → Outperform
2018-08-08 繰り返されました Stifel Hold
2018-08-07 繰り返されました Stifel Hold
2018-05-08 ダウングレード Evercore ISI Outperform → In-line
2017-10-06 再開されました Goldman Sell
2017-08-17 開始されました Evercore ISI Outperform
2017-08-09 繰り返されました Stifel Hold
2017-03-10 ダウングレード Goldman Neutral → Sell
2016-12-28 繰り返されました BMO Capital Markets Outperform
2016-12-27 繰り返されました Leerink Partners Mkt Perform
すべてを表示

Ionis Pharmaceuticals Inc (IONS) 最新ニュース

pulisher
Aug 16, 2026

Ionis Pharmaceuticals Trades at 10.9x Sales as Pipeline Optimism Clashes With Valuation Reality - finance.biggo.com

Aug 16, 2026
pulisher
Aug 16, 2026

Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales - Yahoo Finance

Aug 16, 2026
pulisher
Aug 16, 2026

Empowered Funds LLC Increases Stock Position in Ionis Pharmaceuticals, Inc. $IONS - marketbeat.com

Aug 16, 2026
pulisher
Aug 16, 2026

ETFs Investing in Ionis Pharmaceuticals, Inc. Stocks - TradingView

Aug 16, 2026
pulisher
Aug 15, 2026

Ionis Pharmaceuticals (IONS) Has A $92 Fair Value Narrative, Is The Stock A Bargain? - Yahoo Finance

Aug 15, 2026
pulisher
Aug 15, 2026

IONS Stock Jumps 4% After-Hours — Goldman Sachs Lifts Price Target On Tryngolza Approval - Stocktwits

Aug 15, 2026
pulisher
Aug 14, 2026

Ionis Stock Has Plunged 30%. Is It Time to Buy the Beaten-Down Stock? - The Motley Fool

Aug 14, 2026
pulisher
Aug 14, 2026

Ionis Stock Has Plunged 30%. Is It Time to Buy the Beaten-Down Stock? - The Motley Fool

Aug 14, 2026
pulisher
Aug 12, 2026

Ionis Pharmaceuticals, Inc. $IONS Shares Bought by Handelsbanken Fonder AB - marketbeat.com

Aug 12, 2026
pulisher
Aug 11, 2026

(IONS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Aug 11, 2026
pulisher
Aug 10, 2026

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Assessing Growth Potential with a 57.94% Upside - DirectorsTalk Interviews

Aug 10, 2026
pulisher
Aug 08, 2026

IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire

Aug 08, 2026
pulisher
Aug 08, 2026

3 Healthcare Stocks Retail Investors May Recheck After The July Jobs Shock - Sahm

Aug 08, 2026
pulisher
Aug 07, 2026

Ionis Pharmaceuticals Inc. R (ISI.DU) Q1 FY2026 earnings call transcript - finance.yahoo.com

Aug 07, 2026
pulisher
Aug 07, 2026

Ionis Pharmaceuticals, Inc. $IONS Shares Purchased by Dimensional Fund Advisors LP - marketbeat.com

Aug 07, 2026
pulisher
Aug 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc.IONS - PR Newswire

Aug 06, 2026
pulisher
Aug 06, 2026

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Aug 06, 2026
pulisher
Aug 05, 2026

Ionis Pharmaceuticals, Inc. (IONS) Stock forecasts - Yahoo Finance UK

Aug 05, 2026
pulisher
Aug 04, 2026

Michael Hayden Bought 34% More Shares In Ionis Pharmaceuticals - simplywall.st

Aug 04, 2026
pulisher
Aug 03, 2026

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 72% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews

Aug 03, 2026
pulisher
Aug 03, 2026

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Ionis Pharmaceuticals (NASDAQ:IONS) Stock - marketbeat.com

Aug 03, 2026
pulisher
Aug 02, 2026

Perceptive Advisors LLC Makes New $37.84 Million Investment in Ionis Pharmaceuticals, Inc. $IONS - marketbeat.com

Aug 02, 2026
pulisher
Aug 01, 2026

Ionis Pharmaceuticals, Inc. (IONS) Stock Forecasts - Yahoo Finance

Aug 01, 2026
pulisher
Aug 01, 2026

Ionis Earnings: Early Signs of Commercial Momentum for Tryngolza as Key Catalysts Approach - Morningstar

Aug 01, 2026
pulisher
Aug 01, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) Lowered to "Sell" Rating by Wall Street Zen - marketbeat.com

Aug 01, 2026
pulisher
Jul 31, 2026

IONS5835891 Bond Profile — Key Metrics - TradingView

Jul 31, 2026
pulisher
Jul 31, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) Director Michael Hayden Buys 5,000 Shares - marketbeat.com

Jul 31, 2026
pulisher
Jul 30, 2026

IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook - TradingView

Jul 30, 2026
pulisher
Jul 29, 2026

Ionis Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Jul 29, 2026
pulisher
Jul 29, 2026

Ionis Pharmaceuticals Inc (IONS) Q2 2026 Earnings Call Highlight - GuruFocus

Jul 29, 2026
pulisher
Jul 29, 2026

Ionis Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 29, 2026
pulisher
Jul 29, 2026

Ionis Pharmaceuticals: Q2 Earnings Snapshot - Barchart.com

Jul 29, 2026
pulisher
Jul 29, 2026

Ionis announces Dr. Frank Bennett, chief scientific officer, to retire - Yahoo Finance

Jul 29, 2026
pulisher
Jul 28, 2026

Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% – HBSS - GlobeNewswire

Jul 28, 2026
pulisher
Jul 28, 2026

Ionis Pharmaceuticals, Inc. (IONS) Investigation: Bronstein, Gewi - The National Law Review

Jul 28, 2026
pulisher
Jul 28, 2026

Ionis earnings ahead: Tryngolza launch in focus amid rivalry By Investing.com - Investing.com Nigeria

Jul 28, 2026
pulisher
Jul 28, 2026

Ionis Pharmaceuticals, Inc. (IONS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 28, 2026
pulisher
Jul 27, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Ionis Pharmaceutica - The National Law Review

Jul 27, 2026
pulisher
Jul 27, 2026

Ionis Pharmaceuticals Inc (IONS) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Ionis Pharmaceuticals (IONS) Stock Analysis: Uncovering a Potential 62% Upside in the Biotech Sector - DirectorsTalk Interviews

Jul 27, 2026
pulisher
Jul 27, 2026

Entropy Technologies LP Makes New $2.04 Million Investment in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Jul 27, 2026
pulisher
Jul 27, 2026

Ionis Pharmaceuticals Inc. (IONS) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks

Jul 27, 2026
pulisher
Jul 26, 2026

Bank of New York Mellon Corp Sells 239,269 Shares of Ionis Pharmaceuticals, Inc. $IONS - marketbeat.com

Jul 26, 2026
pulisher
Jul 25, 2026

Ionis Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:IONS - TradingView

Jul 25, 2026
pulisher
Jul 25, 2026

Ionis Pharmaceuticals, Inc. Revenue Breakdown – DUS:ISI - TradingView

Jul 25, 2026
pulisher
Jul 25, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Ionis Pharmaceuticals, Inc. (IONS) And Encourages Investors to Connect - ACCESS Newswire

Jul 25, 2026
pulisher
Jul 25, 2026

Ionis Pharmaceuticals, Inc. $IONS Shares Purchased by KBC Group NV - marketbeat.com

Jul 25, 2026
pulisher
Jul 24, 2026

Ionis Pharmaceuticals Inc (IONS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Ionis Pharmaceuticals Inc (IONS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

TradingKey - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Ionis Pharmaceuticals Inc (IONS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Ionis Pharmaceuticals Inc (IONS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$63.32
price down icon 0.52%
$58.60
price up icon 0.07%
$36.20
price down icon 0.22%
$123.74
price down icon 2.05%
$228.65
price up icon 0.67%
ONC ONC
$347.48
price down icon 2.40%
大文字化:     |  ボリューム (24 時間):